Nov 10, 2023
MSK Doctors (0330 001 0048), a private clinic that specialises in musculoskeletal conditions, regenerative medicine, and minimally or non-invasive therapies, has now been approved as one of the first and only UK clinics able to offer Arthrosamid, a unique single-injection knee treatment.
Sleaford, United Kingdom - November 10, 2023 /PressCable/ —
MSK Doctors have announced their selection as the first clinic in the UK that has been approved to use Arthorsamid injections. This new single-injection option has been extensively tested over several decades and is considered to be one of the few treatments with the potential to provide long-lasting pain relief for osteoarthritis.
More information about Arthrosamid treatments, MSK Doctors, and other non-invasive knee treatments can be found a http://mskdoctors.com/
With this new treatment option, clients can receive a single, minimally invasive injection that’s been shown to reduce or eliminate pain for one year or longer. While research suggests that this pain relief may last significantly longer than one year, follow-up studies are still in progress to determine the maximum pain-reducing lifespan of Arthrosamid.
While knee injections are not new, Arthrosamid differs from traditional options in one important aspect, its biodegradation. With traditional treatment, the injection uses biodegradable materials so that it can be easily absorbed by the body. However, Arthrosamid is not biodegradable, which provides a potential for long-lasting integration into the client’s knee joint.
Although the near-immediate effects of this new treatment are quite similar to the traditional option, the difference becomes apparent after several months, when traditional treatments begin to lose their effectiveness. While both options restore viscosity to provide lubrication and cushioning inside the knee, only Arthrosamid has the potential to become permanently integrated into the synovial fluid, creating a long-term cushioning effect.
In approximately 20 years of testing, Arthrosamid has been shown to be safe for use in the human body, both in long and short-term treatments. While some side effects have been found, they are both minimal and temporary in most cases, such as pain, swelling, or redness at the injection site, which fades within a few days or weeks.
All Arthrosamid treatments at the private MSK Doctors’ clinic are performed by Prof. Paul Lee, the clinic’s founder and a specialist for knee and hip injuries. Prof. Lee is a double-board-certified surgeon with five international fellowships and extensive experience in regenerative and minimally invasive techniques.
Clients can schedule their own appointments for consultation, diagnosis, or treatment of knee conditions, using the MSK Doctors self-booking option. This can be accessed either on the clinic’s website or over the phone, with no waiting list, and clients never require a referral from their GP.
More information about MSK Doctors’ self-booking option, Arthrosamid injections, and Prof. Paul Lee can be found at http://mskdoctors.com/
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89112698
In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com. Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.
MORE NEWS
RECOMMENDED
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.